Growth promoting substance in human mesenchymal stem cells spurs restoration of nerves Published on May 21, 2012 at 10:24 AM A substance in human mesenchymal stem cells that promotes growth appears to spur restoration of nerves and their function in rodent models of multiple sclerosis (MS), researchers at Case Western Reserve University School of Medicine have found.
Managing your bladder with a suprapubic catheter A suprapubic catheter is inserted through your abdomen directly into your bladder. The procedure is usually carried out in Theatre by a surgeon.
Background: Neuromyelitis optica (NMO) is characterized by severe optic neuritis and transverse myelitis. A disease-specific autoantibody against aquaporin (AQP) 4, mainly expressed in astrocytic foot processes, was found in the sera from patients with NMO.
Neuromyelitis optica has not been thoroughly studied in Brazilian patients following the discovery of NMOIgG and its specific antigen aquaporin-4.
Background: Neuromyelitis optica (NMO) is characterized by severe optic neuritis and transverse myelitis. Aquaporin-4 (AQP4) antibody is a diagnostic biomarker of NMO
We report on a patient suffering from symptomatic spinal attacks in the form of a paroxysmal “positive” (algetic-tonic) Brown-S?quard syndrome. A cervical cord lesion, presumably inflammatory-demyelinating in origin, was identified as the morphological correlate of these attacks.
Background: Neuromyelitis optica (NMO) is a rare inflammatory disease. Average age at onset is 35 years. Few data exist on patients with pediatric-onset NMO (p-NMO), with disease onset before age 18 years.
BACKGROUND: Interferon-β-1b (IFNβ-1b) has been used to prevent exacerbation of relapsing-remitting multiple sclerosis (RRMS) including optic-spinal multiple sclerosis (OSMS) in Japan. We encountered 2 patients with OSMS with unexpectedly severe exacerbation soon after the initiation of IFNβ-1b therapy. The experience urged us to retrospectively review the patients with RRMS who had been treated with IFNβ-1b to identify similar cases.
BACKGROUND: Neuromyelitis optica (NMO) is a rare inflammatory disease. Average age at onset is 35 years